Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Daiichi Sankyo
Dow
Cipla
Julphar
Baxter
Healthtrust
Merck

Generated: October 22, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMITRIPTYLINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for amitriptyline hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000428 Combining N-of-1 Trials to Assess Fibromyalgia Treatments Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Phase 4 This study will compare the effectiveness of combination therapy with the drugs amitriptyline and fluoxetine (AM+FL) and amitriptyline (AM) alone in the treatment of people with fibromyalgia. Doctors will treat each study participant with both AM + FL and AM alone for 6 weeks at a time. The study uses a method that combines results from treatment of individual patients to assess overall treatment effectiveness and help individual patients and their physicians with their treatment decisions. This study will also help compare the results of community-based studies (studies involving private doctors) and studies based at clinical research centers.
NCT00000428 Combining N-of-1 Trials to Assess Fibromyalgia Treatments Completed Tufts Medical Center Phase 4 This study will compare the effectiveness of combination therapy with the drugs amitriptyline and fluoxetine (AM+FL) and amitriptyline (AM) alone in the treatment of people with fibromyalgia. Doctors will treat each study participant with both AM + FL and AM alone for 6 weeks at a time. The study uses a method that combines results from treatment of individual patients to assess overall treatment effectiveness and help individual patients and their physicians with their treatment decisions. This study will also help compare the results of community-based studies (studies involving private doctors) and studies based at clinical research centers.
NCT00000793 A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection Completed Boehringer Ingelheim Phase 2 To assess the efficacy, safety, and tolerability of amitriptyline hydrochloride versus mexiletine hydrochloride in reducing pain intensity in patients with HIV-related painful peripheral neuropathy. No large-scale controlled clinical trials of symptomatic therapy for painful HIV-related neuropathy have been attempted. Both amitriptyline and mexiletine have been useful in the management of painful neuropathies; however, both are associated with certain toxicities. In this comparative study of amitriptyline and mexiletine, benztropine mesylate also will be included as an active placebo to mimic the side effects of the study drugs.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for amitriptyline hydrochloride

Condition Name

Condition Name for amitriptyline hydrochloride
Intervention Trials
Fibromyalgia 10
Pain 9
Migraine 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for amitriptyline hydrochloride
Intervention Trials
Neuralgia 10
Myofascial Pain Syndromes 10
Fibromyalgia 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for amitriptyline hydrochloride

Trials by Country

Trials by Country for amitriptyline hydrochloride
Location Trials
United States 144
Canada 12
Brazil 10
Germany 9
Israel 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for amitriptyline hydrochloride
Location Trials
Washington 9
Ohio 8
Illinois 7
New York 7
Florida 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for amitriptyline hydrochloride

Clinical Trial Phase

Clinical Trial Phase for amitriptyline hydrochloride
Clinical Trial Phase Trials
Phase 4 20
Phase 3 21
Phase 2/Phase 3 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for amitriptyline hydrochloride
Clinical Trial Phase Trials
Completed 53
Recruiting 17
Unknown status 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for amitriptyline hydrochloride

Sponsor Name

Sponsor Name for amitriptyline hydrochloride
Sponsor Trials
Federal University of São Paulo 4
Children's Hospital Medical Center, Cincinnati 3
University of Washington 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for amitriptyline hydrochloride
Sponsor Trials
Other 103
Industry 22
NIH 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Farmers Insurance
Cipla
US Army
Fish and Richardson
Teva
Moodys
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.